Recent developments to share with you

Congratulations! Our Company Won Third Prize in 2018 "Chuangye Jinling" Competition

2022-09-12

To implement the municipal party committee and municipal government's plan of building a globally influential innovation city, to create influential public platforms for technology services and innovation competitions, to discover and nurture outstanding innovation projects and entrepreneurial talents, and to promote and support technology startups, the Municipal Science and Technology Commission, together with relevant departments, organized the 2018 "Chuangye Jinling" Technology Innovation and Entrepreneurship Competition.

This year's competition followed the "121" innovation city strategy of the municipal party committee and government. Leveraging various districts and high-tech parks, the competition actively integrated and explored resources, attracting a total of 759 projects. Our company stood out with our project "Development of a Sustained-Release and Controlled-Release Generic and Improved Drug Technology Platform," achieving first place in the biomedical category and advancing to the finals, where we ultimately won third prize.

On August 18, the 2018 "Chuangye Jinling" awards ceremony was held at the Nanjing Broadcasting & Television Station. Leaders from the Municipal Publicity Department, Municipal Human Resources and Social Security Bureau, and Municipal Development and Reform Commission attended the ceremony and presented awards to the outstanding companies. Mr. Yin Laisheng, Chairman of our company, attended the ceremony on behalf of the company. Our company will next represent Nanjing in the 6th "Chuangye Jiangsu" Technology Innovation Competition. We wish our company continued success in the provincial competition!

Keywords：

Our Company Hires Professors in Pharmaceutics and Pharmaceutical Analysis from China Pharmaceutical University as Technical Advisors

Congratulations! Our Company Honored as "Excellent Enterprise" in the 2018 National Entrepreneurship Competition

Related information

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

2026-07-03

Good News | Kangchuanji Pharmaceutical’s Sildenafil Citrate Orally Disintegrating Tablets Have Been Approved for Market Launch

According to the drug approval document delivery information released by the NMPA, sildenafil citrate orally disintegrating tablets manufactured by Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. have been approved for marketing as a Class 4 generic drug under the new chemical drug registration classification, and are deemed to have passed the consistency evaluation.

2026-06-29

A Strong Start to the New Year – Kangchuanji Achieves Multiple Approvals

The new year begins with a wave of good news. Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. has made an excellent start, backed by professional expertise. According to NMPA drug approval information, the following products have been approved for marketing or have passed consistency evaluation: Famotidine Injection (2ml:20mg), Saxagliptin and Metformin Hydrochloride Extended-Release Tablets (2.5/1000mg and 5/1000mg), Isosorbide Dinitrate Tablets (5mg), Vitamin B6 Injection (100mg/ml), Cefdinir Granules (50mg/0.5g), and Ambroxol and Clenbuterol Oral Solution (1ml: ambroxol hydrochloride 1.5mg and clenbuterol hydrochloride 1μg). Among these, Isosorbide Dinitrate Tablets are the first in China to pass consistency evaluation. As a partner, Kangchuanji provided solid pharmaceutical R&D services, successfully supporting these drugs through the review and approval process.

2026-03-23

Please contact us for more detailed information.

Kangchuanji Pharmatech looks forward to working with you and jointly creating a bright future!

Nanjing Kangchuanji Pharmatech Co., Ltd.

Contact Us：18020149597（HR）
Recruitment Email:recruit@kcjpharma.com
Address: 2nd Floor, Building 5, No.199 Wenfang Road, Jiangning District, Nanjing, Jiangsu Province, China（Jiangning High-tech Park）

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

南京康川济医药科技有限公司

Recent developments to share with you

Congratulations! Our Company Won Third Prize in 2018 "Chuangye Jinling" Competition

COOKIES

COOKIES